Interviews

DirectorsTalk Interviews brings investors closer to the people behind listed companies, markets and sectors. We feature interviews with CEOs from UK, US and Canadian companies, alongside fund managers, analysts and sector specialists, giving audiences direct insight into strategy, performance, opportunities and risks. Each interview is designed to help investors understand the businesses shaping the market and make more informed decisions.

INTERVIEWS: Goldplat stock really attractive say VSA

VSA Capital Mining Analyst Oliver O’Donnell talks to DirectorsTalk about today’s announcement from Goldplat Plc (LON:GDP) of the successful commissioning of the first stage of the new processing plant at..

INTERVIEW: Haydale Graphene Industries Plc ‘An excellent platform to launch our products in China’

Haydale Graphene Industries Plc (LON:HAYD) CEO Ray Gibbs talks to DirectorsTalk about a collaboration agreement with Everpower International Holdings Co. Ltd and the strategy to commercialise its technology. Ray explains..

INTERVIEW: OurIT Group Huge skill set to compliment Adept Telecom plc say Northland Capital

Northland Capital Partners Analyst Mike Jeremy talks to DirectorsTalk about Adept Telecom Plc (LON:ADT) new £30m banking facility and acquisition of OurIT Group. Mike explains the rationale for the acquisition..

INTERVIEW: European Metals Holdings Results exceed expectations

European Metals Holdings Ltd (LON:EMH) Managing Director Keith Coughlan talks to DirectorsTalk about its latest drill results and the initial step towards obtaining a mining licence. Keith explains the significance..

INTERVIEW: Ilika Plc Multiple programmes underway in 2017

Ilika Plc (LON:IKA) CFO Steve Boydell talks to DirectorsTalk about a new development project with Seagate Technologies for Hard Drive Technology. Steve explains where the technology will be used, how..

INTERVIEW: Wey Education Plc Reconfirm commitment to ensure quality for teachers and pupils

Wey Education Plc (LON:WEY) Chairman David Massie talks to DirectorsTalk about the announcement of an Academic Advisory Board. David explains the background, talks about its initial members dame Erica Piennar..

INTERVIEW: Falanx Group Ltd Setting 2017 up nicely

Falanx Group Ltd (LON:FLX) CEO Stuart Bladen and Jay Abbott, executive director at Falanx Cyber Defence join DirectorsTalk to talk about the new set up in Birmingham. Stuart explains the..

INTERVIEW: Ascent Resources PLC results have exceeded management’s expectations

Ascent Resources PLC (LON:AST) today announced that it is delighted to report that the flow test at Pg-10 has been successfully completed and the results have exceeded management’s expectations. The..

INTERVIEW: Deltex Medical Group Plc Looking pretty good

Deltex Medical Group Plc (LON:DEMG) CEO Ewan Phillips talks to DirectorsTalk about the benefits of the South Korean health authorities decision to increase the range of medical conditions for which..

INTERVIEWS: Ceres Power Holdings plc CEO Phil Caldwell & Zeus Capital Dr Tom McColm on positive trading update

Ceres Power Holdings plc (LON:CWR) CEO Phil Caldwell chats with DirectorsTalk about it’s latest trading update. Phil talks about the last 6 months, opportunities for the company, the effects of..

INTERVIEW: Immupharma Plc – A multi-billion dollar selling drug

Immupharma Plc (LON:IMM) Non-Executive Chairman Tim McCarthy talks to DirectorsTalk about its phase 3 trial of Lupuzor. Tim explains the importance of completing the recruitment of the 200 patients and..

INTERVIEW: Defenx Plc ‘Café Bazaar the beginning of something exciting’

Defenx Plc (LON:DFX) Chief Financial Officer Philipp Prince talks to DirectorsTalk about it’s latest trading update. Philipp talks us through the update highlights, the integration with Memopal, channel partner network..

INTERVIEW: Northland Capital Vadim Alexandre on ImmuPhrama Plc Phase III trial update

Northland Capital Partners Head of research Vadim Alexandre talks to DirectorsTalk about the phase III trial update announced by Immupharma Plc (LON:IMM). Vadim talks us through the highlights and the..

INTERVIEW: Immupharma Plc A rare opportunity say Northland & Update on Lupuzor Phase III Study

ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, have today provided further details of patient participation following confirmation (as announced on 22 December 2016) that the Company had..

INTERVIEW: Edenville Energy Plc A very exciting and extremely busy time for the company

Edenville Energy Plc (LON:EDL) chief executive officer for Edenville Energy plc Rufus Short talks to DirectorsTalk about its agreement with Sinohydro Corporation. Rufus explains the significance to Edenville, how the..

Toople Plc Business telephony service a great cash generative product

Toople Plc (LON:TOOP) Chief Executive Officer Andy Hollingworth talks to DirectorsTalk about the launch of its new cloud business telephony service. Andy explains what it is and how companies will..

INTERVIEW: Zeus Capital Upgrade forecast for Allergy Therapeutics Plc

Allergy Therapeutics Plc (LON:AGY) is the topic of conversation when DirectorsTalk caught up with Dr Gary Waanders the Director of Healthcare Research at Zeus Capital. Gary explains whats driven growth..

Motif Bio Plc Get updated coverage from Zeus Capital

Motif Bio Plc (LON:MTFB) is the topic of conversation when DirectorsTalk caught up with Dr Gary Waanders the Director of Healthcare Research at Zeus Capital. Gary covers the highlights for..

INTERVIEW: Deltex Medical Group Plc – Continued growth in the USA

Listen to Deltex Medical Group Plc CFO Jonathan Shaw talk to DirectorsTalk about a trading update and its platform account RNS...

INTERVIEW: City of London Investment Group – Now is a good time say Zeus Capital

City of London Investment Group Plc (LON:CLIG) is the topic of conversation with Robin Savage, research director at Zeus Capital. Robin explains why a 61% increase in its profit before..

Search

Funds

Interviews

INTERVIEW: Deltex Medical Group Plc – Continued growth in the USA

Listen to Deltex Medical Group Plc CFO Jonathan Shaw talk to DirectorsTalk about a trading update and its platform account RNS...
Search

Funds

Interviews

FTSE 100

Funds